• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Episode 75: Evolving Science

Shiloh

Shiloh

Editor, Senior Moderator
Source: https://www.cidrap.umn.edu/covid-19/podcasts-webinars/episode-75


Episode 75: Evolving Science
Filed Under: COVID-19
Oct 28, 2021

ep_75.mp3
Credit: CIDRAP

Osterholm Update: COVID-19
Episode 75: Evolving Science
October 28, 2021

In this episode, Dr. Osterholm and Chris Dall discuss what it means to be susceptible to COVID-19, the extent of protection provided by vaccinations and natural immunity, the implications this has for breakthrough infections, and the need for booster doses and vaccinations in children.
Email us your questions: OsterholmUpdate@umn.edu (link sends e-mail)
This podcast is available on Apple Podcasts, Spotify and Google Podcasts. Subscribe on YouTube!
More episodes
 
You must log in or register to reply here.
Back
Top Bottom